Brief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
26/08/2026 21:27
BRIEF-Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting Aug 26 (Reuters) - Interpace Biosciences Inc IDXG.PK:
INTERPACE BIOSCIENCES ANNOUNCES REVERSE STOCK SPLIT TO SUPPORT PROPOSED NASDAQ UPLISTING
INTERPACE BIOSCIENCES - ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT
Source text: ID:nGNXbdPN98
Further company coverage: IDXG.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million